Huntington’s patients waiting on FDA approval after recent discovery of partial cure

A breakthrough recently came in the medical world as doctors say Huntington’s disease – a cruel hereditary disorder that brings with it a combination of ALS, Parkinson’s, and Alzheimer’s symptoms – can now, in part, be cured. However, potential patients in Mississippi and across the country are awaiting FDA approval to be able to take advantage of the treatment.

The treatment was found to be a preliminary success in September after various trials across Europe and North America. Called AMT-130 and produced by developer uniQure, the gene therapy showed a 75% slowing of disease progression in Huntington’s patients by reducing toxic protein in the brain, according to research from the University of Alabama at Birmingham and the University College London.

Huntington’s was long considered unt